300 related articles for article (PubMed ID: 16400746)
1. Hypersexuality due to dopaminergic drugs.
Prescrire Int; 2005 Dec; 14(80):224. PubMed ID: 16400746
[TBL] [Abstract][Full Text] [Related]
2. Dopamine agonist: pathological gambling and hypersexuality.
Prescrire Int; 2008 Oct; 17(97):200-1. PubMed ID: 19536937
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists.
Singh A; Kandimala G; Dewey RB; O'Suilleabhain P
J Clin Neurosci; 2007 Dec; 14(12):1178-81. PubMed ID: 17720504
[TBL] [Abstract][Full Text] [Related]
4. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2011 Jan; 9(101):1-6; quiz 2 p following 6. PubMed ID: 21304446
[No Abstract] [Full Text] [Related]
5. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Montastruc JL; Schmitt L; Bagheri H
Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
[TBL] [Abstract][Full Text] [Related]
6. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease.
Avanzi M; Uber E; Bonfà F
Neurol Sci; 2004 Jun; 25(2):98-101. PubMed ID: 15221629
[TBL] [Abstract][Full Text] [Related]
7. Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases.
Shapiro MA; Chang YL; Munson SK; Okun MS; Fernandez HH
Parkinsonism Relat Disord; 2006 Sep; 12(6):392-5. PubMed ID: 16730214
[TBL] [Abstract][Full Text] [Related]
8. Impulsive and compulsive behaviors in Parkinson's disease.
Evans AH; Strafella AP; Weintraub D; Stacy M
Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
[TBL] [Abstract][Full Text] [Related]
9. Medical hazards of the internet: gambling in Parkinson's disease.
Larner AJ
Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
[No Abstract] [Full Text] [Related]
10. Dopamine agonists and therapy compliance.
Grosset D
Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
[TBL] [Abstract][Full Text] [Related]
11. Pathological gambling and hypersexuality due to dopaminergic treatment in Parkinson' disease.
Martín Fernández F; Martín González T
Actas Esp Psiquiatr; 2009; 37(2):118-22. PubMed ID: 19401861
[TBL] [Abstract][Full Text] [Related]
12. [Hypersexuality during use of levodopa].
van Deelen RA; Rommers MK; Eerenberg JG; Egberts AC
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2095-8. PubMed ID: 12448966
[TBL] [Abstract][Full Text] [Related]
13. [Sexual delinquency and Parkinson's disease].
Berger Ch; Mehrhoff FW; Beier KM; Meinck HM
Nervenarzt; 2003 Apr; 74(4):370-5. PubMed ID: 12707708
[TBL] [Abstract][Full Text] [Related]
14. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
Klos KJ; Bower JH; Josephs KA; Matsumoto JY; Ahlskog JE
Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of parkinsonism and legal capacity].
Wallesch CW
Fortschr Neurol Psychiatr; 2011 Aug; 79(8):441. PubMed ID: 21809256
[No Abstract] [Full Text] [Related]
16. A case of hedonistic homeostatic dysregulation.
Kessel BL
Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
[TBL] [Abstract][Full Text] [Related]
17. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
[TBL] [Abstract][Full Text] [Related]
18. Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.
Odiyoor M; Kobylecki C; Hackett RJ; Silverdale MA; Kellett MW
Mov Disord; 2009 Dec; 24(16):2434-5. PubMed ID: 19891000
[No Abstract] [Full Text] [Related]
19. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease.
Drapier D; Drapier S; Sauleau P; Derkinderen P; Damier P; Allain H; Vérin M; Millet B
Psychiatry Res; 2006 Nov; 144(2-3):241-4. PubMed ID: 17011634
[TBL] [Abstract][Full Text] [Related]
20. Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
Wenzelburger R
Clin Neurophysiol; 2005 Sep; 116(9):1997-8. PubMed ID: 16055380
[No Abstract] [Full Text] [Related]
[Next] [New Search]